Registry of Aortic Valve Bioprostheses Established by Catheter

The aim of this registry is to evaluate the overall survival up to 10 years of patients with aortic valve bioprostheses implanted via the transarterial or transapical route. Data from the register is enhanced by matching it with continuous data in the SNDS. Mandated by the French health authorities, this registry must be maintained as part of the management of any patient undergoing transarterial or transapical aortic valve bioprosthesis implantation. Participation in the registry is offered to all subjects eligible for bioprosthesis implantation.

NCT Number	NCT01777828
Lead Sponsor	French Cardiology Society
Conditions	Transcatheter Aortic Valve Implantation
Enrollment	5,000 participants
Start Date	2013-02
Primary Completion	2033-02 (estimated)
Study Completion	2034-02 (estimated)
Updated on ClinicalTrials.gov	2025-02-14